Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Presentation EuroPCR 2024

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

Presenter: Hans-Josef Feistritzer

May 14, 2024

Presentation Miami Valves 2024

New Cerebral Protection Devices for TAVR

Presenter: Fábio S. Brito Jr.

February 03, 2024

Presentation Interventional Complications 2022

TAVR and Unexplained Hypotension: An Algorithmic Approach

Presenter: Frederick Welt

July 15, 2022

Presentation

Diastolic BP and Heart Rate Are Associated With Mortality in Chronic Aortic Regurgitation

January 08, 2020

Presentation CHIP Seattle 2019

Causes & Management of Hemodynamic Collapse after TAVR

Presenter: Jamie McCabe

August 02, 2019

Presentation

RAS Inhibition Following TAVR

July 29, 2019

Presentation

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

February 06, 2019

Presentation

TAVR in Oncology Patients With Severe AS

January 10, 2019

Presentation TCT 2018

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

Presenter: John G. Webb

September 23, 2018

Presentation

Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist TAVR

January 16, 2018

Presentation

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

October 17, 2017

Presentation

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

September 27, 2017

Presentation

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

August 22, 2017

Presentation

Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R)

February 09, 2017

Presentation

Early Clinical Outcomes with Self-Expandable TAVR System (Evolut R) in Severe AS

Presenter: Jeffrey Popma

February 09, 2017

Presentation TVT 2016

TVT 1176: Compassionate Use of a Self-Expanding Aortic Valve Bioprosthesis in Severe Aortic Regurgitation Without Aortic Stenosis or Annular Calcification

Presenter: Mehul Patel, MD

June 17, 2016

Presentation TVT 2016

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Presenter: Ganesh Manoharan

June 17, 2016

Presentation TVT 2016

TVT 1162: Calcium and the Rising EDP TAVR and Same-Setting PVL Closure

Presenter: Jonathon M. White

June 16, 2016

Presentation

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Presenter: G. Michael Deeb

April 06, 2016

Advertisement

Continuation versus Interruption of Oral Anticoagulation during TAVI

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

New Cerebral Protection Devices for TAVR

TAVR and Unexplained Hypotension: An Algorithmic Approach

Diastolic BP and Heart Rate Are Associated With Mortality in Chronic Aortic Regurgitation

Causes & Management of Hemodynamic Collapse after TAVR

RAS Inhibition Following TAVR

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

TAVR in Oncology Patients With Severe AS

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist TAVR

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R)

Early Clinical Outcomes with Self-Expandable TAVR System (Evolut R) in Severe AS

TVT 1176: Compassionate Use of a Self-Expanding Aortic Valve Bioprosthesis in Severe Aortic Regurgitation Without Aortic Stenosis or Annular Calcification

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

TVT 1162: Calcium and the Rising EDP TAVR and Same-Setting PVL Closure

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content